Evaluation of a new screening assay ProCρ Global for identification of defects in the protein C/protein S anticoagulant pathway

Thrombosis Research

Volumn 87, Issue 6, 1997, Pages 501-510

  Ruzicka, Katharina ^a   Kapiotis, Stylianos ^a   Quehenberger, Peter ^a   Handler, Sylvia ^a   Pabinger Fasching, Ingrid ^b   Mannhalter, Christine ^a   Jilma, Bernd ^a   Speiser, Wolfgang ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b Division of Hematology   (Austria)

Author keywords

Evaluation in thrombophilia patients; ProC Global assay

Indexed keywords

ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; HEPARIN; LUPUS ANTICOAGULANT; PROTEIN S;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; SCREENING TEST; THROMBOEMBOLISM; THROMBOPHILIA; VEIN THROMBOSIS;

ADMINISTRATION, ORAL; ADULT; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; EVALUATION STUDIES; FEMALE; HEPARIN; HUMANS; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PROTEIN C; PROTEIN C DEFICIENCY; PROTEIN S; PROTEIN S DEFICIENCY; PROTHROMBIN TIME; SENSITIVITY AND SPECIFICITY; TEMPERATURE;

EID: 0030862638     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(97)00179-5     Document Type: Article

References (10)

1. DE STEFANO V., FINAZZI G., MANNUCCI P.M. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood. 87:1996;3531-3544.
2. ROSENBERG R.D., ROSENBERG J.S. Natural anticoagulant mechanisms. J Clin Invest. 74:1984;1-4.
3. WALKER F.J., FAY P.J. Regulation of blood coagulation by the protein C system. FASEB J. 6:1993;2561-2567.
4. DAHLBÄCK B., CARLSSON M., SVENSSON P.J. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA. 90:1993;1004-1008.
5. BERTINA R.M., KOELEMAN B.P.C., KOSTER T., ROSENDAAL F.R., DIRVEN R.J., DE RONDE H., VAN DER VELDEN P.A., REITSMA P.H. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 369:1994;64-67.
6. KRAUS M., NOAH M., FICKENSCHER K. The PCAT - a simple screening assay for assessing the functionality of the protein C anticoagulant pathway. Thromb Res. 79:1995;217-222.
7. ROBERT E., ESCHWEGE V., HAMEG H., DROUET L., AILLAUD M.F. Anticoagulant response to Agkistrodon contortrix venom (ACV) test: a new global test to screen for defects in the anticoagulant protein C pathway. Thromb Haemost. 75:1996;562-565.
8. KAPIOTIS S., QUEHENBERGER P., JILMA B., HANDLER S., PABINGER-FASCHING I., MANNHALTER C., SPEISER W. Improved characteristics of aPC-Resistance assay Coatest® aPC™® resistance by predilution of samples with factor V deficient plasma. Am J Clin Pathol. 106:1996;588-593.
9. BERTINA R.M., KOELEMAN B.P.C., KOSTER T., ROSENDAAL F.R., DIRVEN R.J., DE RONDE H., VAN DER VELDEN P.A., REITSMA P.H. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 369:1994;64-67.
10. KRAUS M., NOAH M., Fickenscher K. The PCAT-a simple screening assay for assessing the functionality of the protein C anticoagulant pathway. Thromb Res. 79:1995;217-222.